News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Chris Boshoff: The European Medicines Agency (EMA) has accepted our application in collaboration with Astellas Pharma US and Merck for a combination therapy for advanced Urothelial Cancer
Photo of Chris Boshoff from LinkedIn
Feb 1, 2024, 04:54

Chris Boshoff: The European Medicines Agency (EMA) has accepted our application in collaboration with Astellas Pharma US and Merck for a combination therapy for advanced Urothelial Cancer

Chris Boshoff, Chief Oncology Officer and Executive Vice President at Pfizer, shared on LinkedIn:

”The European Medicines Agency (EMA) has accepted our application in collaboration with Astellas Pharma US and Merck for a combination therapy for advanced Urothelial Cancer.

People living with bladder cancer in Europe face poor outcomes at the advanced stage, and innovative therapies are needed. This acceptance marks a significant milestone in our commitment to enhancing treatment options for people with bladder cancer.

Read more here.”

Chris Boshoff: The European Medicines Agency (EMA) has accepted our application in collaboration with Astellas Pharma US and Merck for a combination therapy for advanced Urothelial Cancer

Source: Chris Boshoff/LinkedIn

Astellas Pharma US bladder cancer cancer Chris Boshoff europe European Medicines Agency Merck OncoDaily Oncology
Special Coverage
Science
Jan 20, 2025, 15:25
Tony Hung: A virtual integrative medicine program to improve symptoms and decrease hospitalization
Blog
Jan 20, 2025, 14:46
Gregg Margolis: Three things to read about health policy this week
Blog
Jan 20, 2025, 14:43
Afreen Shariff: Excellent to connect with fellow board members at the ACCC
Dialogues
Jan 20, 2025, 14:32
The Current Situation with Colorectal Cancer in Kazakhstan
Science
Jan 20, 2025, 14:17
Hung Trinh: Bispecific Antibodies in Cancer Therapy
Insight
Jan 20, 2025, 14:16
Amy Moore: Ensuring that all patients benefit from recent scientific advances in lung cancer
Blog
Jan 20, 2025, 14:04
Emily Drake: I finally joined Bluesky
Insight
Jan 20, 2025, 14:03
Richard Sullivan: Radiotherapy is the core modality in cancer care with proven ROI
Blog
Jan 20, 2025, 13:56
Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer
Blog
Jan 20, 2025, 13:56
Luis Felipe Tapias: It has been 4 years since I started as a Thoracic Surgeon at Mayo Clinic
Opinion
Jan 20, 2025, 13:56
Amol Akhade: Do oncologists from LMICs and HICs treat and read about only certain solid tumors or all of them?
Blog
Jan 20, 2025, 13:55
Mayo Clinic Transplant completed over 2,000 solid organ transplants in 2024